Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
Cutaneous lesions caused by Leishmania major in BALB/c mice were cured completely when treated topically with an ointment comprising 15% paromomycin sulphate and 1-2% methylbenzethonium chloride ointment in soft white paraffin twice daily for 10 days. No parasites were detected in tissue smears or in cultures from treated cutaneous lesions. Re-developing lesions, considered to be resulting from the migration of parasites from internal organs, showed almost the same response to topical treatment. Promastigotes of the virulent clone 121 of L. major LRC-L137 which were exposed to 100 micrograms ml-1 of paromomycin in RPMI medium at 28 degrees C developed resistance to the drug over 10 passages of exposure. Enzyme analysis of susceptible and resistant promastigotes of this clone showed no differences with regard to their profiles based on 11 enzymes.
el-On
J
J
Department of Microbiology and Immunology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel.
Sulitzeanu
A
A
Schnur
L F
LF
D000287:Administration, Topical; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001558:Benzethonium / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D007895:Leishmania tropica / Q000187:drug effects* / Q000201:enzymology; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D010303:Paromomycin / Q000627:therapeutic use*; D013997:Time Factors
D000891:Anti-Infective Agents, Local; D001558:Benzethonium; D010303:Paromomycin; C005106:methylbenzethonium chloride